This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer | MicrobiomeTrials
← Back to trials NCT07472868
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-03-16Est. Completion: 2030-03-02
Enrollment target: 394 participantsLocations Radiotherapiegroep, Arnhem, Gelderland, Netherlands Rijnstate, Arnhem, Gelderland, Netherlands CWZ, Nijmegen, Gelderland, Netherlands Radboudumc, Nijmegen, Gelderland, Netherlands Maastro, Maastricht, Limburg, Netherlands Maastricht UMC+, Maastricht, Limburg, Netherlands SJG Weert, Weert, Limburg, Netherlands Jeroen Bosch ziekenhuis, 's-Hertogenbosch, North Brabant, Netherlands Catharina Hospital Eindhoven, Eindhoven, North Brabant, Netherlands Elkerliekziekenhuis, Helmond, North Brabant, Netherlands Máxima MC, Veldhoven, North Brabant, Netherlands Antoni van Leeuwenhoek, Amsterdam, North Holland, Netherlands Amsterdam UMC, Amsterdam, North Holland, Netherlands Deventer Ziekenhuis, Deventer, Overijssel, Netherlands Isala, Zwolle, Overijssel, Netherlands Frisius MC, Leeuwarden, Provincie Friesland, Netherlands Radiotherapeutisch Instituut Friesland, Leeuwarden, Provincie Friesland, Netherlands Haaglanden Medisch Centrum, Leidschendam, South Holland, Netherlands Other microbiome trials you might be interested in Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage II Lung Non-Small Cell Cancer AJCC v7 Stage IIA Lung Cancer AJCC v8 Stage IIB Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Lung Cancer AJCC v8
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that ha…
Birmingham, United States Est. completion Dec 3, 2025
Erasmus MC, Rotterdam, South Holland, Netherlands
UMC Utrecht, Utrecht, Utrecht, Netherlands Clinical Stage: Stage II (T3-4, N-)
Stage III (Any T, N+)
Solid Tumor
Solid Tumor, Adult
The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the ch…
Hartford, United States Est. completion Nov 30, 2026
Solid Tumor
Genes contain genetic code which tell the body which proteins to make. Some types of cancer are caused by changes, or mu…
Westwood, United States Completed Jun 18, 2026